List of Tables
Table 1. Global Anti-Herpesvirus Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anti-Herpesvirus Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anti-Herpesvirus Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-Herpesvirus Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Anti-Herpesvirus Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anti-Herpesvirus Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anti-Herpesvirus Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anti-Herpesvirus Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anti-Herpesvirus Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-Herpesvirus Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Herpesvirus Drug, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Herpesvirus Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Herpesvirus Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Herpesvirus Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Herpesvirus Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anti-Herpesvirus Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Anti-Herpesvirus Drug Sales Market Share by Region (2020-2025)
Table 19. Global Anti-Herpesvirus Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Anti-Herpesvirus Drug Sales Market Share by Region (2026-2031)
Table 21. Global Anti-Herpesvirus Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anti-Herpesvirus Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Anti-Herpesvirus Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anti-Herpesvirus Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Anti-Herpesvirus Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anti-Herpesvirus Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Anti-Herpesvirus Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Anti-Herpesvirus Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anti-Herpesvirus Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anti-Herpesvirus Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anti-Herpesvirus Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Anti-Herpesvirus Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Anti-Herpesvirus Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anti-Herpesvirus Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anti-Herpesvirus Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anti-Herpesvirus Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Anti-Herpesvirus Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Anti-Herpesvirus Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anti-Herpesvirus Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-Herpesvirus Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anti-Herpesvirus Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Anti-Herpesvirus Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Anti-Herpesvirus Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-Herpesvirus Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anti-Herpesvirus Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anti-Herpesvirus Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Anti-Herpesvirus Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Anti-Herpesvirus Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anti-Herpesvirus Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anti-Herpesvirus Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Anti-Herpesvirus Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Anti-Herpesvirus Drug Sales Market Share by Type (2020-2025)
Table 53. Global Anti-Herpesvirus Drug Sales Market Share by Type (2026-2031)
Table 54. Global Anti-Herpesvirus Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anti-Herpesvirus Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anti-Herpesvirus Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Anti-Herpesvirus Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Anti-Herpesvirus Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Anti-Herpesvirus Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Anti-Herpesvirus Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Anti-Herpesvirus Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Anti-Herpesvirus Drug Sales Market Share by Application (2020-2025)
Table 63. Global Anti-Herpesvirus Drug Sales Market Share by Application (2026-2031)
Table 64. Global Anti-Herpesvirus Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anti-Herpesvirus Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anti-Herpesvirus Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Anti-Herpesvirus Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Anti-Herpesvirus Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Anti-Herpesvirus Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Greater Pharma Company Information
Table 71. Greater Pharma Description and Business Overview
Table 72. Greater Pharma Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Greater Pharma Anti-Herpesvirus Drug Product
Table 74. Greater Pharma Recent Developments/Updates
Table 75. LBS Labs Company Information
Table 76. LBS Labs Description and Business Overview
Table 77. LBS Labs Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. LBS Labs Anti-Herpesvirus Drug Product
Table 79. LBS Labs Recent Developments/Updates
Table 80. GlaxoSmithKline Company Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. GlaxoSmithKline Anti-Herpesvirus Drug Product
Table 84. GlaxoSmithKline Recent Developments/Updates
Table 85. Lex Ano Company Information
Table 86. Lex Ano Description and Business Overview
Table 87. Lex Ano Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Lex Ano Anti-Herpesvirus Drug Product
Table 89. Lex Ano Recent Developments/Updates
Table 90. Salutas Company Information
Table 91. Salutas Description and Business Overview
Table 92. Salutas Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Salutas Anti-Herpesvirus Drug Product
Table 94. Salutas Recent Developments/Updates
Table 95. Novartis Company Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Novartis Anti-Herpesvirus Drug Product
Table 99. Novartis Recent Developments/Updates
Table 100. Teva Company Information
Table 101. Teva Description and Business Overview
Table 102. Teva Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Teva Anti-Herpesvirus Drug Product
Table 104. Teva Recent Developments/Updates
Table 105. Stada Nordic Company Information
Table 106. Stada Nordic Description and Business Overview
Table 107. Stada Nordic Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Stada Nordic Anti-Herpesvirus Drug Product
Table 109. Stada Nordic Recent Developments/Updates
Table 110. Cimed Industria de Medicamentos Company Information
Table 111. Cimed Industria de Medicamentos Description and Business Overview
Table 112. Cimed Industria de Medicamentos Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Cimed Industria de Medicamentos Anti-Herpesvirus Drug Product
Table 114. Cimed Industria de Medicamentos Recent Developments/Updates
Table 115. Reman Drug Company Information
Table 116. Reman Drug Description and Business Overview
Table 117. Reman Drug Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Reman Drug Anti-Herpesvirus Drug Product
Table 119. Reman Drug Recent Developments/Updates
Table 120. L.E.T.I. Company Information
Table 121. L.E.T.I. Description and Business Overview
Table 122. L.E.T.I. Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. L.E.T.I. Anti-Herpesvirus Drug Product
Table 124. L.E.T.I. Recent Developments/Updates
Table 125. Nichi-Iko Pharmaceutical Company Information
Table 126. Nichi-Iko Pharmaceutical Description and Business Overview
Table 127. Nichi-Iko Pharmaceutical Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Nichi-Iko Pharmaceutical Anti-Herpesvirus Drug Product
Table 129. Nichi-Iko Pharmaceutical Recent Developments/Updates
Table 130. Choseido Pharmaceutical Company Information
Table 131. Choseido Pharmaceutical Description and Business Overview
Table 132. Choseido Pharmaceutical Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Choseido Pharmaceutical Anti-Herpesvirus Drug Product
Table 134. Choseido Pharmaceutical Recent Developments/Updates
Table 135. Shiono Kemikaru Company Information
Table 136. Shiono Kemikaru Description and Business Overview
Table 137. Shiono Kemikaru Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Shiono Kemikaru Anti-Herpesvirus Drug Product
Table 139. Shiono Kemikaru Recent Developments/Updates
Table 140. Towa Yakuhin Company Information
Table 141. Towa Yakuhin Description and Business Overview
Table 142. Towa Yakuhin Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Towa Yakuhin Anti-Herpesvirus Drug Product
Table 144. Towa Yakuhin Recent Developments/Updates
Table 145. Wockhardt Company Information
Table 146. Wockhardt Description and Business Overview
Table 147. Wockhardt Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Wockhardt Anti-Herpesvirus Drug Product
Table 149. Wockhardt Recent Developments/Updates
Table 150. Takata Pharmaceutical Company Information
Table 151. Takata Pharmaceutical Description and Business Overview
Table 152. Takata Pharmaceutical Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Takata Pharmaceutical Anti-Herpesvirus Drug Product
Table 154. Takata Pharmaceutical Recent Developments/Updates
Table 155. Aliud Company Information
Table 156. Aliud Description and Business Overview
Table 157. Aliud Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Aliud Anti-Herpesvirus Drug Product
Table 159. Aliud Recent Developments/Updates
Table 160. Amneal Pharma Company Information
Table 161. Amneal Pharma Description and Business Overview
Table 162. Amneal Pharma Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Amneal Pharma Anti-Herpesvirus Drug Product
Table 164. Amneal Pharma Recent Developments/Updates
Table 165. Apotex Company Information
Table 166. Apotex Description and Business Overview
Table 167. Apotex Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Apotex Anti-Herpesvirus Drug Product
Table 169. Apotex Recent Developments/Updates
Table 170. Arrow Company Information
Table 171. Arrow Description and Business Overview
Table 172. Arrow Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Arrow Anti-Herpesvirus Drug Product
Table 174. Arrow Recent Developments/Updates
Table 175. Laboratoires Servier Company Information
Table 176. Laboratoires Servier Description and Business Overview
Table 177. Laboratoires Servier Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. Laboratoires Servier Anti-Herpesvirus Drug Product
Table 179. Laboratoires Servier Recent Developments/Updates
Table 180. Sanofi Company Information
Table 181. Sanofi Description and Business Overview
Table 182. Sanofi Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. Sanofi Anti-Herpesvirus Drug Product
Table 184. Sanofi Recent Developments/Updates
Table 185. Mylan Company Information
Table 186. Mylan Description and Business Overview
Table 187. Mylan Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 188. Mylan Anti-Herpesvirus Drug Product
Table 189. Mylan Recent Developments/Updates
Table 190. Orion Pharma Company Information
Table 191. Orion Pharma Description and Business Overview
Table 192. Orion Pharma Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 193. Orion Pharma Anti-Herpesvirus Drug Product
Table 194. Orion Pharma Recent Developments/Updates
Table 195. Pfizer Company Information
Table 196. Pfizer Description and Business Overview
Table 197. Pfizer Anti-Herpesvirus Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 198. Pfizer Anti-Herpesvirus Drug Product
Table 199. Pfizer Recent Developments/Updates
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Anti-Herpesvirus Drug Distributors List
Table 203. Anti-Herpesvirus Drug Customers List
Table 204. Anti-Herpesvirus Drug Market Trends
Table 205. Anti-Herpesvirus Drug Market Drivers
Table 206. Anti-Herpesvirus Drug Market Challenges
Table 207. Anti-Herpesvirus Drug Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
Table 211. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-Herpesvirus Drug
Figure 2. Global Anti-Herpesvirus Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-Herpesvirus Drug Market Share by Type: 2024 & 2031
Figure 4. Lovir Drugs Product Picture
Figure 5. Foscarnet Sodium Product Picture
Figure 6. Adenosine Product Picture
Figure 7. Other Product Picture
Figure 8. Global Anti-Herpesvirus Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Anti-Herpesvirus Drug Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Global Anti-Herpesvirus Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Anti-Herpesvirus Drug Market Size (2020-2031) & (US$ Million)
Figure 15. Global Anti-Herpesvirus Drug Sales (2020-2031) & (K Units)
Figure 16. Global Anti-Herpesvirus Drug Average Price (US$/Unit) & (2020-2031)
Figure 17. Anti-Herpesvirus Drug Report Years Considered
Figure 18. Anti-Herpesvirus Drug Sales Share by Manufacturers in 2024
Figure 19. Global Anti-Herpesvirus Drug Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Anti-Herpesvirus Drug Players: Market Share by Revenue in Anti-Herpesvirus Drug in 2024
Figure 21. Anti-Herpesvirus Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Anti-Herpesvirus Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Anti-Herpesvirus Drug Sales Market Share by Country (2020-2031)
Figure 24. North America Anti-Herpesvirus Drug Revenue Market Share by Country (2020-2031)
Figure 25. United States Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Anti-Herpesvirus Drug Sales Market Share by Country (2020-2031)
Figure 28. Europe Anti-Herpesvirus Drug Revenue Market Share by Country (2020-2031)
Figure 29. Germany Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Anti-Herpesvirus Drug Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Anti-Herpesvirus Drug Revenue Market Share by Region (2020-2031)
Figure 36. China Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Anti-Herpesvirus Drug Sales Market Share by Country (2020-2031)
Figure 44. Latin America Anti-Herpesvirus Drug Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Anti-Herpesvirus Drug Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Anti-Herpesvirus Drug Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Anti-Herpesvirus Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Anti-Herpesvirus Drug by Type (2020-2031)
Figure 55. Global Revenue Market Share of Anti-Herpesvirus Drug by Type (2020-2031)
Figure 56. Global Anti-Herpesvirus Drug Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Anti-Herpesvirus Drug by Application (2020-2031)
Figure 58. Global Revenue Market Share of Anti-Herpesvirus Drug by Application (2020-2031)
Figure 59. Global Anti-Herpesvirus Drug Price (US$/Unit) by Application (2020-2031)
Figure 60. Anti-Herpesvirus Drug Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
